Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.

Weitere Versionen anzeigen (1)

OBJECTIVE: Impaired endothelial function, characterized by nitric oxide scavenging by increased superoxide production, is a hallmark of vascular disease states. However, molecular mechanisms regulating superoxide production in human blood vessels remain poorly defined. METHODS AND RESULTS: We compa...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Guzik, T, Sadowski, J, Kapelak, B, Jopek, A, Rudzinski, P, Pillai, R, Korbut, R, Channon, K
Format:	Journal article
Sprache:	English
Veröffentlicht:	2004

Ähnliche Einträge

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins
von: Guzik, T, et al.
Veröffentlicht: (2004)

Superoxide production by NAD(P)H oxidases in human bypass graft vessels - Role in the regulation of vascular tone
von: Guzik, T, et al.
Veröffentlicht: (2002)

Vascular superoxide production in human coronary artery disease. Relationships between Nox expression and oxidase activity
von: Guzik, T, et al.
Veröffentlicht: (2004)

Superoxide generation by NAD(P)H oxidases in human bypass graft vessels.
von: Guzik, T, et al.
Veröffentlicht: (2002)

Coronary artery superoxide production and nox isoform expression in human coronary artery disease.
von: Guzik, T, et al.
Veröffentlicht: (2006)

Increased NAD(P)H oxidase activity in coronary arteries from patients with coronary artery disease
von: Guzik, T, et al.
Veröffentlicht: (2001)

Mechanisms of increased vascular superoxide generation in human coronary arteries from patients with coronary artery disease
von: Guzik, T, et al.
Veröffentlicht: (2002)

Superoxide generation by NAD(P)H oxidase in human sphenous vein: Interaction with nitric oxide
von: Guzik, T, et al.
Veröffentlicht: (2000)

Increased vascular oxidative stress inpatients with type II diabetes mellitus is mediated by protein kinase C
von: Guzik, T, et al.
Veröffentlicht: (2002)

Relationships of promoter and coding sequence genetic polymorphisms of p22phox subunit to the vascular NAD(P)H oxidase activity
von: Guzik, T, et al.
Veröffentlicht: (2004)

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.
von: Guzik, T, et al.
Veröffentlicht: (2002)

Vascular superoxide generation by NAD(P)H oxidase is increased in humans with type II diabetes mellitus
von: Guzik, T, et al.
Veröffentlicht: (2001)

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
von: Kim, Y, et al.
Veröffentlicht: (2005)

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.
von: Kim, Y, et al.
Veröffentlicht: (2005)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation (AF)
von: Kim, Y, et al.
Veröffentlicht: (2003)

Systemic upregulation of vascular NAD(P)H oxidase in human atherosclerosis: Association with clinical risk factors.
von: Guzik, T, et al.
Veröffentlicht: (2000)

Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.
von: Guzik, T, et al.
Veröffentlicht: (2000)

Superoxide dismutase activity and expression in human venous and arterial bypass graft vessels.
von: Guzik, T, et al.
Veröffentlicht: (2005)

UltraRapid communications : vascular superoxide production by NAD(P)H OxidaseAssociation with endothelial dysfunction and clinical risk factors
von: Guzik, T, et al.
Veröffentlicht: (2000)

Functional impact of genetic polymorphisms in NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis
von: Guzik, T, et al.
Veröffentlicht: (2000)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
von: Kim, Y, et al.
Veröffentlicht: (2005)

Protein kinase C mediates increased vascular oxidative in stress in patients with type II diabetes mellitus
von: Guzik, T, et al.
Veröffentlicht: (2002)

Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis.
von: Guzik, T, et al.
Veröffentlicht: (2000)

Functional importance of C242T polymorphism in NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis
von: Guzik, T, et al.
Veröffentlicht: (2000)

Superoxide production by NAD(P)H oxidase in human blood vessels: Functional interaction with nitric oxide
von: Guzik, T, et al.
Veröffentlicht: (2000)

Relationship of NAD(P)H oxidase activity in human blood vessels to endothelial dysfunction and clinical risk factors
von: Guzik, T, et al.
Veröffentlicht: (2000)

Association of superoxide production by NAD(P)H oxidase with systaemic endothelial dysfunction in human blood vessels: relationship to clinical risk factors
von: Guzik, T, et al.
Veröffentlicht: (2000)

Atrial NAD(P)H oxidase activity predicts the development of atrial fibrillation after coronary artery bypass graft surgery
von: Kim, Y, et al.
Veröffentlicht: (2006)

Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.
von: West, N, et al.
Veröffentlicht: (2001)

Atrial NAD(P)H oxidase activity predicts the development of atrial fibrillation after on-pump coronary artery bypass graft surgery
von: Kim, Y, et al.
Veröffentlicht: (2005)

Enhanced superoxide anion production in experimental venous bypass grafts is mediated by NAD(P)H oxidase
von: West, N, et al.
Veröffentlicht: (2000)

NOX family NADPH oxidases in mammals: Evolutionary conservation and isoform-defining sequences
von: Bahareh Nazari, et al.
Veröffentlicht: (2023-10-01)

Superoxide generation during cardiopulmonary bypass in conventional coronary artery bypass graft surgery: is there a role for myocardial NAD(P)H oxidase?
von: Kim, Y, et al.
Veröffentlicht: (2004)

Mechanisms of oxidative stress in human aortic abdominal aneurysms - Role of iNOS, NADPH oxidase and relationship to clinical features.
von: Guzik, B, et al.
Veröffentlicht: (2006)

NADPH Oxidase 5 Is a Pro‐Contractile Nox Isoform and a Point of Cross‐Talk for Calcium and Redox Signaling‐Implications in Vascular Function
von: Augusto C. Montezano, et al.
Veröffentlicht: (2018-06-01)

NADPH Oxidase Isoform 2 (NOX2) Is Involved in Drug Addiction Vulnerability in Progeny Developmentally Exposed to Ethanol
von: Marcela L. Contreras, et al.
Veröffentlicht: (2017-06-01)

NOX, NOX who is there?, The contribution of NADPH Oxidase to beta cell dysfunction.
von: David eTaylor-Fishwick
Veröffentlicht: (2013-04-01)

Direct effects of 5-methyl-tetrahydrofolate on vascular endotheliurn and superoxide production in human arteries and veins
von: Antoniades, C, et al.
Veröffentlicht: (2006)

Effects of NADPH Oxidase Isoform-2 (NOX2) Inhibition on Behavioral Responses and Neuroinflammation in a Mouse Model of Neuropathic Pain
von: Luísa Teixeira-Santos, et al.
Veröffentlicht: (2023-01-01)

NOX isoforms in the development of abdominal aortic aneurysm
von: Kin Lung Siu, et al.
Veröffentlicht: (2017-04-01)